The cost of CAR T-cell therapy means that the highly effective cancer treatment is unavailable in many parts of the world.
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single ...
CAR T-cell therapy is considered a milestone in personalized cancer treatment. In this approach, a patient's own immune cells ...
Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...
Sequencing CAR T-cell therapy versus bispecific antibodies in myeloma increasingly hinges on MRD depth, transplant candidacy, ...
Persistent viral infections pose a unique challenge to the immune system. Prolonged antigen exposure drives T cells into a state of exhaustion — a ...
Targeted extended circulation LNP achieved complete B cell depletion in nonhuman primates through highly specific in vivo CD8+ T cell engineering ...
Researchers from The University of Osaka find that only a small fraction of T cells may drive the robust anti-cancer response ...
Luke Pase and Prof. Fujiwara discuss how new targeting strategies and scalable manufacturing approaches are advancing ...
A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results